NCT06634641View on ClinicalTrials.gov

Clozapine-related Immunodeficiency in Parkinson's Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
ClozapineParkinson's Disease (PD)ImmunodeficiencyPsychosis
Interventions
BIOLOGICAL

blood test

Only carrying out additional immunological assays during blood tests before initiation of treatment, six months after initiation of treatment and then one year after initiation of treatment.

Trial Locations (1)

80480

RECRUITING

CHU Amiens-Picardie, Salouël

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER